Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| iQIYI, Inc.IQ · Entity 5046 | Senior Vice President | May 11, 2026 | May 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
iQIYI, Inc.
Report date May 11, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2027-02-14 | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-11 · Disposition to issuer · Disposed 4,812,117 · Balance 0 F4: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. F3: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2030-10-18 | Direct | 4,812,117 |
Reported balance
After 2026-05-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-11 · Grant · Acquired 4,812,117 · Balance 4,812,117 F4: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. F3: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2028-02-28 | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-11 · Disposition to issuer · Disposed 5,600,000 · Balance 0 F6: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. F5: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2030-10-18 | Direct | 5,600,000 |
Reported balance
After 2026-05-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-05-11 · Grant · Acquired 5,600,000 · Balance 5,600,000 F6: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. F5: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2036-05-11 | Direct | 2,275,000 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 2,275,000 F1: The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-05-11 | Direct | 2,450,000 |
Reported balance
Holding disclosure · report date 2026-05-11 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 2,450,000 F2: The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
F2: The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.
F3: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
F4: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.
F5: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
F6: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2026 Filed May 13, 2026 12:30 UTC | iQIYI, Inc. IQ · Entity 5046 | GrantOption (right to buy) · Derivative | 5,600,000 | Not disclosed Strike: $0.51 | Not disclosed |
DisclosureSEC source: 0001966549-26-000002 · ownership.xml · derivative · entry 6 Yang Xianghua · CIK 0001966549 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,600,000 Underlying: Class A ordinary share · 5,600,000 shares Expires 2030-10-18 F6 · price: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. F5 · derivative.exercise_date: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. Read SEC document |
| May 11, 2026 Filed May 13, 2026 12:30 UTC | iQIYI, Inc. IQ · Entity 5046 | Disposition to issuerOption (right to buy) · Derivative | 5,600,000 | Not disclosed Strike: $0.51 | Not disclosed |
DisclosureSEC source: 0001966549-26-000002 · ownership.xml · derivative · entry 5 Yang Xianghua · CIK 0001966549 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary share · 5,600,000 shares Expires 2028-02-28 F6 · price: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030. F5 · derivative.exercise_date: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. Read SEC document |
| May 11, 2026 Filed May 13, 2026 12:30 UTC | iQIYI, Inc. IQ · Entity 5046 | GrantOption (right to buy) · Derivative | 4,812,117 | Not disclosed Strike: $0.51 | Not disclosed |
DisclosureSEC source: 0001966549-26-000002 · ownership.xml · derivative · entry 4 Yang Xianghua · CIK 0001966549 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,812,117 Underlying: Class A ordinary share · 4,812,117 shares Expires 2030-10-18 F4 · price: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. F3 · derivative.exercise_date: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. Read SEC document |
| May 11, 2026 Filed May 13, 2026 12:30 UTC | iQIYI, Inc. IQ · Entity 5046 | Disposition to issuerOption (right to buy) · Derivative | 4,812,117 | Not disclosed Strike: $0.51 | Not disclosed |
DisclosureSEC source: 0001966549-26-000002 · ownership.xml · derivative · entry 3 Yang Xianghua · CIK 0001966549 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary share · 4,812,117 shares Expires 2027-02-14 F4 · price: The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. F3 · derivative.exercise_date: The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.